title: Osteoclast inhibitory lectin, an immune cell product that is required for normal bone physiology in vivo.
abstract: Osteoclast inhibitory lectin (OCIL or clrb) is a member of the natural killer cell C-type lectins that have a described role mostly in autoimmune cell function. OCIL was originally identified as an osteoblast-derived inhibitor of osteoclast formation in vitro. To determine the physiological function(s) of OCIL, we generated ocil(-/-) mice. These mice appeared healthy and were fertile, with no apparent immune function defect, and phenotypic abnormalities were limited to bone. Histomorphometric analysis revealed a significantly lower tibial trabecular bone volume and trabecular number in the 10- and 16-week-old male ocil(-/-) mice compared with wild type mice. Furthermore, ocil(-/-) mice showed reduced bone formation rate in the 10-week-old females and 16-week-old males while Static markers of bone formation showed no significant changes in male or female ocil(-/-) mice. Examination of bone resorption markers in the long bones of ocil(-/-) mice indicated a transient increase in osteoclast number per unit bone perimeter. Enhanced osteoclast formation was also observed when either bone marrow or splenic cultures were generated in vitro from ocil(-/-) mice relative to wild type control cultures. Loss of ocil therefore resulted in osteopenia in adult mice primarily as a result of increased osteoclast formation and/or decreased bone formation. The enhanced osteoclastic activity led to elevated serum calcium levels, which resulted in the suppression of circulating parathyroid hormone in 10-week-old ocil(-/-) mice compared with wild type control mice. Collectively, our data suggest that OCIL is a physiological negative regulator of bone.
authors.affiliation: St. Vincent's Institute, 9 Princes Street, Fitzroy, Victoria 3065, Australia.
authors.forename: Vicky
authors.initials: V
authors.lastname: Kartsogiannis
authors.forename: Natalie A
authors.initials: NA
authors.lastname: Sims
authors.forename: Julian M W
authors.initials: JM
authors.lastname: Quinn
authors.forename: Chi
authors.initials: C
authors.lastname: Ly
authors.forename: Mirijana
authors.initials: M
authors.lastname: Cipetic
authors.forename: Ingrid J
authors.initials: IJ
authors.lastname: Poulton
authors.forename: Emma C
authors.initials: EC
authors.lastname: Walker
authors.forename: Hasnawati
authors.initials: H
authors.lastname: Saleh
authors.forename: Narelle E
authors.initials: NE
authors.lastname: McGregor
authors.forename: Morgan E
authors.initials: ME
authors.lastname: Wallace
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Smyth
authors.forename: T John
authors.initials: TJ
authors.lastname: Martin
authors.forename: Hong
authors.initials: H
authors.lastname: Zhou
authors.forename: Kong Wah
authors.initials: KW
authors.lastname: Ng
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Gillespie
mesh_terms: D000818:Animals; D001851:Bone Diseases, Metabolic / Q000097:blood / Q000235:genetics; D001862:Bone Resorption / Q000097:blood / Q000235:genetics; D002118:Calcium / Q000097:blood; D005260:Female; D006801:Humans; D037181:Lectins, C-Type / Q000235:genetics / Q000378:metabolism*; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D009929:Organ Size / Q000502:physiology; D010010:Osteoclasts / Q000378:metabolism*; D010012:Osteogenesis / Q000502:physiology*; D013977:Tibia / Q000378:metabolism*
chemical_list: D037181:Lectins, C-Type; D008565:Membrane Proteins; C429003:Ocil protein, mouse; D002118:Calcium
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3527-32
references.pmid: 14990792
references.citation: Arthritis Res Ther. 2007;9(2):103
references.pmid: 17381830
references.citation: Nat Rev Immunol. 2007 Apr;7(4):292-304
references.pmid: 17380158
references.citation: J Biol Chem. 2001 May 4;276(18):14916-23
references.pmid: 11278931
references.citation: J Exp Med. 2000 Nov 20;192(10):1467-78
references.pmid: 11085748
references.citation: J Bone Miner Res. 1987 Dec;2(6):595-610
references.pmid: 3455637
references.citation: Cell Immunol. 2005 Mar;234(1):39-53
references.pmid: 15963483
references.citation: J Clin Invest. 1998 Feb 1;101(3):595-603
references.pmid: 9449693
references.citation: Endocrinology. 2003 Jun;144(6):2597-605
references.pmid: 12746323
references.citation: Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E456-62
references.pmid: 16204337
references.citation: Annu Rev Immunol. 2006;24:33-63
references.pmid: 16551243
references.citation: Nat Rev Immunol. 2003 Apr;3(4):304-16
references.pmid: 12669021
references.citation: J Biol Chem. 2002 Dec 13;277(50):48808-15
references.pmid: 12374791
references.citation: J Bone Miner Res. 2004 Jan;19(1):89-99
references.pmid: 14753741
references.citation: Immunogenetics. 2001 Apr;53(3):209-14
references.pmid: 11398965
references.citation: J Biol Chem. 2004 Jul 9;279(28):29043-9
references.pmid: 15123656
references.citation: Clin Chem. 1992 Jun;38(6):904-8
references.pmid: 1597016
references.citation: Bone. 2007 Feb;40(2):305-15
references.pmid: 17049328
references.citation: Bone. 2002 Jan;30(1):18-25
references.pmid: 11792560
references.citation: Calcif Tissue Int. 2008 May;82(5):348-53
references.pmid: 18465072
references.citation: J Bone Miner Res. 2003 Aug;18(8):1486-96
references.pmid: 12929938
references.citation: J Cell Biochem. 2003 Sep 1;90(1):158-69
references.pmid: 12938165
references.citation: J Cell Physiol. 1992 Apr;151(1):197-205
references.pmid: 1373147
references.citation: Nat Immunol. 2003 Aug;4(8):801-7
references.pmid: 12858173
references.citation: J Exp Med. 1992 Jul 1;176(1):47-58
references.pmid: 1613465
references.citation: Biochem Biophys Res Commun. 2005 Mar 18;328(3):739-45
references.pmid: 15694408
references.citation: J Immunol. 2001 Apr 15;166(8):4915-21
references.pmid: 11290769
references.citation: Int Immunol. 1993 Aug;5(8):957-64
references.pmid: 8398989